New gene therapies may soon treat dozens of rare diseases, but million-dollar price tags will put them out of reach for many
By Kevin Doxzen (Hoffmann Postdoctoral Fellow, Arizona State University) Zolgensma – which treats spinal muscular atrophy, a rare genetic disease...
Read moreDetails